“Ozempic causes hair loss.”
What the evidence shows
Hair loss is a documented, if uncommon, side effect. The FDA prescribing information for Wegovy lists alopecia as an adverse reaction, reported by about 3% of adults on semaglutide 2.4 mg versus 1% on placebo — and the label explicitly notes the hair loss was associated with weight reduction. The label notes the shedding tracked with the amount of weight lost. The leading explanation is telogen effluvium: a temporary, diffuse shedding that any large, fast weight loss — or major physical stress — can trigger, as a wave of hair follicles shift into their resting phase weeks after the trigger.
What we still don’t know
We can't yet cleanly separate how much is pure telogen effluvium from rapid loss, how much is nutritional (rapid loss can shortchange iron, zinc, protein), and whether the drug has any direct effect on hair follicles, which do carry GLP-1 receptors. A 2025 systematic review (Cureus) found conflicting results — some studies noting shedding, others regrowth — and none can prove the drug itself is the cause rather than the weight loss it produces; long-term follow-up is thin.
Why the claim misleads
"Causes hair loss" makes it sound like a direct drug toxicity that keeps stripping your hair. What the evidence points to is the classic shedding that follows rapid weight loss by any method — typically self-limited, peaking a few months in and recovering as weight stabilizes and nutrition catches up. It is a real quality-of-life issue worth raising with a clinician (who can check iron and protein), not proof the medicine is attacking your body.
Graded by The Peptide Era · evidence, not hype